Comparing Rotigotine vs Sinemet
| Rotigotine | Sinemet (carbidopa / levodopa) |
|
|---|
| Rotigotine | Sinemet (carbidopa / levodopa) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Restless Legs Syndrome, Parkinson's Disease. Rotigotine may also be used for purposes not listed in this medication guide. |
Prescription only
Sinemet is a medication that may be used for the treatment of Parkinson's disease that is available in three different strengths: Sinemet 25/100, Sinemet 25/250, and Sinemet 10/100. Dyskinesias... View more |
Related suggestions Restless Legs Syndrome
Parkinson's Disease
|
|||||||
| More about Rotigotine | More about Sinemet (carbidopa / levodopa) | ||||||||
| Ratings & Reviews | |||||||||
|
Rotigotine has an average rating of 7.7 out of 10 from a total of 75 ratings on Drugs.com. 69% of reviewers reported a positive effect, while 12% reported a negative effect. |
Sinemet has an average rating of 7.7 out of 10 from a total of 30 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 10% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
View all Rotigotine side effects |
View all Sinemet side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Sinemet prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Neupro | Other carbidopa / levodopa brands include: Atamet, Crexont, Dhivy, Duopa, Parcopa, Rytary | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
7 hours |
2.3 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | |||||||||
|
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 257 drugs are known to interact with Rotigotine:
|
A total of 521 drugs are known to interact with Sinemet:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
May 09, 2007 |
May 02, 1975 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Requip
Requip is used to treat symptoms of Parkinson's disease, such as stiffness, tremors and muscle ...
Mirapex
Mirapex (pramipexole) treats the symptoms of Parkinson's disease and is also used to treat Restless ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Neupro
Neupro Skin Patches (rotigotine) are used to treat early signs and symptoms of Parkinson's disease ...
Horizant
Horizant (gabapentin enacarbil) is used to treat restless legs syndrome and nerve pain caused by ...
Inbrija
Inbrija is an inhaled medicine used to treat the symptoms of Parkinson's disease. Includes side ...
Gabapentin enacarbil
Gabapentin enacarbil is used for alcohol use disorder, postherpetic neuralgia, restless legs syndrome
Levodopa
Levodopa is used for parkinson's disease, parkinsonism, periodic limb movement disorder, restless ...
Pramipexole
Pramipexole is used for parkinson's disease, periodic limb movement disorder, restless legs ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.